NCT00619398View on ClinicalTrials.gov

A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Liver Transplantation
Interventions
DRUG

Prograf

Oral

DRUG

FK506MR capsule

Oral

Trial Locations (6)

Unknown

Beijing

Guangzhou

Shenyang

Shanghai

Hangzhou

Tianjing

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY